The chemical compound identified by CAS No. 1421312-34-6, Methyl 4-Hydroxy-1-Methyl-7-Phenoxy-3-Isoquinolinecarboxylate, stands as a testament to the intricate building blocks that drive pharmaceutical innovation. Ningbo Inno Pharmchem Co., Ltd. recognizes its crucial function as an intermediate in the synthesis of Roxadustat, a significant therapeutic agent for managing anemia. This molecule's unique structural features and high purity are indispensable for researchers and manufacturers focused on creating effective treatments.

The ability to efficiently produce compounds like Methyl 4-Hydroxy-1-Methyl-7-Phenoxy-3-Isoquinolinecarboxylate is central to the success of modern pharmaceutical endeavors. Our focus on the methyl 4-hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylate synthesis ensures that the chemical properties meet the demanding requirements for drug formulation. As leading scientific research chemical suppliers, we are committed to providing materials that accelerate breakthroughs in medical science.

The market for roxadustat intermediate manufacturing relies on a stable supply of high-quality precursors. Ningbo Inno Pharmchem Co., Ltd. plays a vital role in this ecosystem, ensuring that researchers and developers have access to the compounds they need for their critical projects. Whether it’s for the development of treatments for anemia or exploring new therapeutic avenues, the quality of intermediates like this isoquinolinecarboxylate is key.

By providing reliable access to essential chemicals, Ningbo Inno Pharmchem Co., Ltd. actively contributes to the progression of pharmaceutical science. We believe that understanding the detailed applications and synthetic pathways of compounds such as CAS 1421312-34-6 empowers our clients to achieve greater success in their research and development endeavors, ultimately benefiting patient health worldwide.